Executive Committee

Steffen Saltofte

CEO

MBA, IMD International, Lausanne, Switzerland

Bachelor, International Business & Economic and Strategic Market Management, Copenhagen Business School, Denmark

Danish citizen

Function in Group Management

Chief Executive Officer and Member of Group Management since 30 May, 2018

Professional background

  • 2017-17

    Chief Operating Officer, EVP Global Commercial Operations at Boehringer Ingelheim Animal Health in France and Germany

  • 2014-17

    Chief Operating Officer, Senior Vice President and Head Business Operations at Merial (Sanofi-group) in France

  • 2011-14

    Managing Director Nordic at Syngenta in Switzerland

  • 2009-11

    Integration Manager, Merger & Acquisitions at Syngenta in Switzerland

  • 2006-07

    General Manager at Maersk Line in Denmark

  • 2004-06

    Manager at Maersk Sealand in Denmark

  • 1999-03

    Rising to Branch Manager at Maersk Sealand in Saudi Arabia


Gary Hughes

CFO

Honours Degree in Law of Leeds University, UK

British citizen

Function in Group Management

Chief Financial Officer Acino Group and Member of Group Management since 1 July 2018

Professional background

  • 2017-18

    Interim Chief Financial Officer at Solifos AG in Windisch, Switzerland

  • 2016-17

    Chief Financial Officer at Equatex AG in Zurich, Switzerland

  • 2013-16

    Chief Financial Officer at Selecta Management AG in Cham, Switzerland

  • 2008-13

    Group Financial Controller at Selecta Management AG in Cham, Switzerland

  • 2004-08

    Head of Financial Reporting and Accounting at Ciba Vision AG in Embrach, Switzerland

  • 2001-04

    Senior Manager, Assurance Services at Ernst & Young in Manchester, UK and Zurich, Switzerland

  • 1999-01

    Financial Reporting Lecturer at Accountancy Tuition Centres in Manchester, UK

  • 1994-99

    Supervisor Assurance Services at Ernst & Young in Manchester, UK


Konstantin Bakaykin

Corporate Development Officer and Head of Commercial Regions

Degree from the Geological Academy of Russian Federation, Moscow, Russia

Russian citizen

Function in Group Management

Head of Corporate Business Development and Member of Group Management since May 16, 2014

Professional background

  • 2012-14

    Head of Business Development for Emerging Markets, Takeda Pharmaceuticals International GmbH, Zurich

  • 2008-12

    Director of Business Development and Marketing Intelligence, Nycomed Russia CIS

  • 2007-08

    Marketing Manager Rx portfolio, Nycomed

  • 2002-07

    Franchise Manager, Bristol-Myers Squibb

  • 1997-02

    Marketing Director, Deputy General Manager, ASTA Medica AG

  • 1997-98

    Head of Consumer Healthcare, ASTA Medica AG

  • 1995-97

    Promotions Manager, SmithKline Beecham pls, Moscow


Andrew Bird

General Manager MEA

MBA, Cranfield School of Management, Cranfield

PhD in Organic Chemistry, University of York, York

BSc (Hons) Chemistry, University of East Anglia, Norwich

Citizen of United Kingdom

Function in Group Management

General Manager MEA and member of the Acino Executive Committee since October 1st, 2018.

Professional background

  • 2017-18

    General Manager Gulf, Eastern Mediterranean & Maghreb Region, Dubai

  • 2011-17

    Strategy & Operations Director Middle East, Africa & India

  • 2016-17

    General Manager Maghreb Region at Bristol-Myers Squibb

  • 2013-14

    General Manager South Africa at Bristol-Myers Squibb

  • 2011-11

    Business Director at Pase II Gulf, Dubai

  • 2009-10

    Regional Marketing Director Africa & Middle East (AfME)

  • 2008-09

    Senior European brand Manager at Pfizer

  • 1999-07

    Sales & Marketing roles at Janssen-Cilag Ltd. Uk & Ireland

  • 1997-98

    Medicinal Chemist at Cerebrus Ltd.

  • 1996-97

    Research Chemist at Glaxowellcome

  • 1995-96

    Production Manager at Croda International


Anthony Durieux-Menage

Group HR Director

Biotechnology Engineer of Institut National des Sciences Appliquées, Toulouse, France

French citizen

Function in Group Management

Group HR Director and Member of Group Management since November 13, 2017

Professional background

  • 2017-17

    HR Director Switzerland at Acino, Switzerland

  • 2013-17

    Senior HR Business Partner at Novartis, Switzerland

  • 2012-13

    Head of Operational Excellence & HR Site Head at Novartis, Switzerland

  • 2010-13

    Head of Operational Excellence & QC Head at Novartis, France

  • 2002-10

    Production Engineer/Unit Manager at Ajinomoto Eurolysine S.A.S., France

  • 1997-02

    Development Engineer/Production Unit Coordinator at Lesaffre, Belgium, Austria and France


Eugene Zaika

Head Ukraine and CIS

DBA degree (ongoing), International Management Institute (IMI-Kyiv)

MBA, International Management Institute (IMI-Kyiv)

PhD in cardiology, Research Institute of Therapy (Academy of Medical Science of Ukraine)

MD, Kharkiv Medical Institute, honors

Ukrainian Citizen

Professional background

  • 2011-15

    Takeda Cluster Head for Ukraine, Belarus, Moldova and Israel / General Director LLC Takeda Ukraine

  • 2008-11

    General Director, LLC Nycomed Ukraine

  • 2005-08

    Head of Represenative office of Nycomed in Ukraine and Moldova

  • 2005-05

    Marketing Manager, Sanofi-Aventis Ukraine and Moldova

  • 2000-04

    Marketing Manager, Aventis Intercontinental (Ukraine)

  • 1998-00

    East Ukraine Area Manager, Rhone-Poulenc Rorer (Ukraine)

  • 1994-97

    Medical representative, Rhone-Poulenc Rorer (Ukraine)

  • 1993-97

    Cardiologist, scientific associate in the department of clinical pharmacology, Research Institute of Therapy (Kharkiv)


Sébastien Geneve

Head of Global Medical and Regulatory Affairs

Pharmaceutical doctor from the University of Clermont-Ferrand and Post Graduate Diploma in Pharmacology, Drug Development and Regulation from the Tuft Medical School in Boston, USA.

French citizen

Function in Group Management

Head of Global Medical Affairs, Regulatory Affairs and Pharmacovigilance and Member of Group Management since August, 2016

Professional background

  • 2015-16

    Vice-President Global Regulatory Affairs at Bayer Consumer Care, Basel

  • 2012-15

    Vice-President International Regulatory Affairs at Bayer Consumer Care, Basel

  • 2008-12

    Director Regulatory Affairs Pharmaceutical EMEA at Bausch & Lomb in Zug

  • 2005-08

    Head Regulatory Affairs Gastro-intestinals and other therapeutic areas at Bayer Consumer Care, Basel

  • 2003-04

    Head Regulatory Affairs Gastro-intestinals at Roche Consumer Health near Basel

  • 2000-03

    Global Regulatory Affairs Manager at Roche Consumer Health near Basel

  • 1998-00

    Manager Dossier and Regulatory Issues at Galderma R&D in Princeton, New Jersey, USA

  • 1997-98

    Clinical Project Manager at Galderma Laboratories in Forth Worth, Texas, USA

  • 1996-97

    Scientific Writer at CIRD Galderma in Sophia Antipolis, France


Christina Peusch

Chief Legal & Compliance Officer

German qualified lawyer, University of Passau, Passau, Germany

German citizen

Function in Group Management

Chief Legal & Compliance Officer and Member of Group Management from March 16, 2015

Professional background

  • 2013-15

    Head of Legal EUCAN (Europe/Canada), Emerging Markets and North Asia, Takeda Pharmaceuticals International GmbH, Zurich

  • 2012-13

    Senior Director Corporate Legal Affairs, Takeda Pharmaceuticals International GmbH, Zurich

  • 2010-12

    Senior Director International Legal Affairs, Nycomed Germany Holding GmbH, Konstanz, Germany

  • 2007-09

    Director International Legal Affairs, Nycomed Germany Holding GmbH, Konstanz, Germany

  • 2004-07

    International Legal Affairs Manager, Altana Pharma AG, Konstanz, Germany

  • 1995-04

    Clifford Chance (prev. Pünder, Volhard, Weber & Axster), member of the Commercial Law and Corporate Finance practice areas and (chief) representative of the Beijing office; Frankfurt am Main and Munich, Germany, and Beijing, PRC.


Mario Ricard

Chief Operations Officer

Master of Business Administration and Bachelor of Science – Mechanical Engineering from the University of Sherbrooke in Canada.

Canadian citizen

Function in Group Management

Chief Operations Officer and Member of Group Management since February 15, 2017

Professional background

  • 2015-17

    Vice President – Plasma Manufacturing Europe at Baxalta/Shire, Zurich

  • 2014-15

    Vice President – Operations Strategy at Baxter, Zurich

  • 2012-14

    Vice President – Technical Services and BioSurgery Manufacturing at Baxter, Belgium and Switzerland

  • 2010-12

    Operations Director at Baxter, Belgium

  • 2003-10

    Plant Manager at Baxter, Belgium

  • 1999-03

    Plant Manager at Baxter, Canada

  • 1992-99

    Various roles in Production, Purchasing and Planning at Baxter, Canada


Ulrike Seminati

Head of Corporate Communications

Masters Degree in Marketing Management, EM Business School of Robert Schuman University in Strasbourg, France

German citizen

Function in Group Management

Head of Corporate Communications and Member of Group Management since July 1, 2015

Professional background

  • 2013-15

    Head of Communications Switzerland, Syngenta Crop Protection AG, Basel, Switzerland

  • 2011-13

    Global Internal Communications Manager, Syngenta Crop Protection AG, Basel, Switzerland

  • 2009-11

    Communications Services Manager, Syngenta International AG, Basel, Switzerland

  • 2006-07

    Online Marketing Manager, Arte TV, Strasbourg, France

  • 2000-06

    Head of Communication Center smart, Daimler Group, Hambach, France

  • 1996-00

    PR-Manager at Magna Automotive in Hambach, France


Board of Directors

Håkan Björklund

Ph.D. in Neuroscience, Karolinska Institutet, Sweden

Swedish citizen

Board membership and executive mandates within the Acino Group

  • Chairman of the Board of Acino International AG since December 17, 2013
  • Current term of office on the Board expires in 2018

Professional background

Håkan Björklund joined Avista Capital Partners in October 2011. Mr. Björklund is the former Chief Executive Officer of Nycomed, which was sold to Takeda Pharmaceuticals in September 2011. Under Mr. Björklund’s leadership, Nycomed grew from a predominantly Scandinavian business into a global pharmaceutical company with leading market positions in Europe, Russia/CIS, Brazil and Latin America. Prior to Nycomed, Mr. Björklund was Regional Director at Astra (now AstraZeneca) and, earlier, President of Astra Draco. He is Chairman of the Board of Directors at Lundbeck A/S, a member of the Board of Directors of Alere Inc., Coloplast A/S and Atos Medical AB. He was also a director at Danisco A/S until its recent acquisition by Dupont.


Tom Dean

BA, University of Virginia, USA; MBA, Harvard Business School, USA

Citizen of the Untied States of America

Board membership and executive mandates within the Acino Group

  • Member of the Board of Acino International AG since
    December 17, 2013
  • Current term of office expires in 2018

Professional background

Tom Dean is the Co-Managing Partner and Co-CEO of Avista Capital Partners. Prior to co-founding Avista Capital Partners in 2005, Mr. Dean led DLJ Merchant Banking Partners (“DLJMB”), serving as Co-Managing Partner of DLJMB since 1995 and Chairman of the Investment Committees of DLJMB I, DLJMB II, DLJMB III and DLJ Growth Capital Partners through December 2007. Mr. Dean currently serves on the boards of ConvaTec, Sidewinder Drilling, Zest Anchors, and VWR International. Mr. Dean formerly served as the Chairman of the board of Nycomed, Arcade, DeCrane Aircraft, Mueller and Von Hoffmann. He also formerly served on the boards of American Ref-Fuel, Argyle Television, BioPartners, Charles River Labs, Evergreen Media, Merrill, Safilo, Visant and IWCO Direct Holdings, among others.


Johan Ek

MSc in Economics, Hanken School of Economics in Helsinki, Finland

Citizen of Sweden

Board membership and executive mandates within the Acino Group

  • Member of the Board of Acino International AG since February 22, 2017
  • Current term of office on the Board expires in 2018

Professional background

Johan Ek, has worked as an Industrial Advisor to the Nordic Capital Funds since July 2012. Johan is currently Chairman of the Board of Sunrise Medical and Saferoad and vice Chairman of the Board of Handicare. He was previously Chairman on the board of CPS. Johan also works as an investor through his own business. Johan started his career at McKinsey & Company as a management consultant. He then joined LGP Allgon AB and served in various positions including President, and later became President of Business Unit Europe at Powerwave Technologies Inc. between 2005-2012, Johan worked as President and CEO of the Relacom Group.


Olof Faxander

MSc in Engineering from the Swedish Royal Institute of Technology and a B.A. Economics from the Stockholm University.

Swedish citizen

Board membership and executive mandates within the Acino Group

  • Member of the Board of Acino International AG since
    April 18, 2018
  • Current term of office expires in 2019

Professional background

Joined NC Advisory, Advisor to the Nordic Capital funds, in January 2016. Olof is head of the Operational Team which provides operational support to portfolio companies. Olof has extensive experience in leadership roles in large industrial companies where he spent the first 20 years of his career. Since joining, Olof has been driving the Operational Excellence effort and working on establishing and developing Nordic Capital’s Operations Team. Olof is board member of several of portfolio companies. Prior to joining, his most recent positions were as CEO of two large public industrial groups, Sandvik (2011–2015) and SSAB (2006–2010).


Kunal Pandit

M.A. and B.A., Cambridge University, USA
MBA, Wharton School at the University of Pennsylvania, USA

Citizen of the United Kingdom

Board membership and executive mandates within the Acino Group

  • Member of the Board of Acino International AG since December 17, 2013
  • Current term of office expires in 2018

Professional background

Kunal Pandit joined Avista Capital Partners in 2010. Mr. Pandit was previously at DLJ Merchant Banking Partners (“DLJMB”) in London. Prior to DLJMB, Mr. Pandit was a member of the leveraged finance group and the investment banking department at Lehman Brothers in London. He currently serves as a director of Guala Closures.


Thomas Vetander

M.Sc. in Engineering Physics, Royal Institute of Technology of Stockholm, Sweden
B.Sc. in Business Administration and Economics, Stockholm University School of Business, Sweden

Swedish citizen

Board membership and executive mandates within the Acino Group

  • Member of the Board of Acino International AG since December 17, 2013
  • Current term of office expires in 2018

Professional background

Thomas Vetander joined NC Advisory AB, advisor to the Nordic Capital funds, in 2006. From 2004 to 2006, Mr. Vetander worked as a Management Consultant at McKinsey & Company in Stockholm. Mr. Vetander serves on the board of Handicare and as a deputy board member of Convatec.


Toni Weitzberg

B.Sc. in Economics and Business Administration, University of Uppsala, Sweden; MBA, University of Wisconsin, USA

Citizen of Sweden

Board membership and executive mandates within the Acino Group

  • Vice-Chairman of the Board of Acino International AG since December 17, 2013
  • Current term of office expires in 2018

Professional background

Toni Weitzberg joined NC Advisory AB, advisor to the Nordic Capital funds, in 2000. Prior to joining, Mr. Weitzberg held various executive positions within the Pharmacia Group, most recently as Senior Vice President and Head of Pharmacia Europe. He currently serves as a board member of Convatec and Handicare. Mr. Weitzberg is the former Chairman of Dynal, Biovitrum, Atos, Nycomed, as well as a former board member of Fougera Pharmaceuticals, Unomedical and Permobil.


Alex Yu

B.A., Northwestern University, USA, MBA, Wharton School at the University of Pennsylvania, USA

Citizen of the United States of America

Board membership and executive mandates within the Acino Group

  • Member of the Board of Acino International AG since October 19, 2017
  • Current term of office on the Board expires in 2018

Professional background

Alex Yu joined Avista Capital Partners in 2017. Mr. Yu is a Vice President at Avista Capital Partners. He joined Avista Capital Partners in 2017. Prior to joining Avista, Mr. Yu worked in the Private Equity Group at Goldman Sachs. Prior to joining Goldman Sachs, he worked as an Associate at Fenway Partners and as an Analyst in the Technology Group at Lehman Brothers and Barclays Capital. He currently serves on the boards of Inform Diagnostics and Trimb Healthcare.